The central finding of this study is the existence of a potent, selective, and direct inhibitor of p22phox with enhances inhibitory activity against ROS-producing NOX (p22phox) and Rubicon interaction (an interaction that leads to ROS production from RA in mice in vivo and in human cells ex vivo). This evidence concerns the gene CYBA and rheumatoid arthritis.